 




<DOCTITLE>University of Colorado Board of Regents; Prospective Grant of Exclusive Patent License</DOCTITLE>



<AGENCY>
AGENCY: 

National Institute of Standards and Technology, Commerce.



</AGENCY>
<ACTION>
ACTION: 

Notice of Prospective Grant of Exclusive Patent License.






</ACTION>
<SUMMARY>
SUMMARY: 

This notice is in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i) that the National Institute of Standards
and Technology (``NIST''), U.S. Department of Commerce, is contemplating the grant of an exclusive license in the
United States to practice the invention embodied in U.S. Patent Application 07/935,016, titled, ``Perflourinated
Inonomer Membrane Invention'' to The Board of Regents of the University of Colorado, having a place of business in
Boulder, Colorado. This invention was co-developed by employees of the University of Colorado and NIST. The inventors'
respective patent rights in this invention have been assigned to The University of Colorado and the United States
of America.




</SUMMARY>
<FURTHER>
FOR FURTHER INFORMATION CONTACT:



Bruce E. Mattson, National Institute of Standards and Technology, Technology Development and Small Business Program,
Building 221, room B256, Gaithersburg, MD 20899.



</FURTHER>
<SUPPLEM>
SUPPLEMENTARY INFORMATION: 

The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within sixty days from the date of this
published Notice, NIST receives written evidence and argument which establish that the grant of the license would
not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. The University of Colorado will have the right
to, and intends to, grant sublicenses to commercial entities desiring to use the method.



U.S. Patent Application 07/935,016 relates to a process describing the method for producing an improved perfluorinated
ionomer membrane with an improved transport characteristic.

NIST may enter into a Cooperative Research and Development Agreement (``CRADA'') to perform further research on
the invention for purposes of commercialization. The CRADA may be conducted by NIST without any additional charge
to any party that licenses the patent. NIST may grant the licensee an option to negotiate for royalty-free exclusive
licenses to any jointly owned inventions which arise from the CRADA as well as an option to negotiate for exclusive
royalty-bearing licenses for NIST employee inventions which arise from the CRADA.

The availability of U.S. Patent Application 07/935,016 was published in the 

Federal Register,

 Vol. 59, No. 208 (October 28,1 994). A copy of the patent application maybe obtained from the University of Colorado.





Dated: November 30, 1994.


</SUPPLEM>
<SIGNER>
Samuel Kramer,


</SIGNER>
<SIGNJOB>
Associate Director.


</SIGNJOB>
<FRFILING>
[FR Doc. 9429949 Filed 12594; 8:45 am]


</FRFILING>
<BILLING>
BILLING CODE 351013M
</BILLING>




